A 27 year-old woman presenting with the clinical picture characterized by hypersomnolence, mild psychomotor retardation, dystonia, oculomotor apraxia, weakness, and striking diurnal variations of symptoms was found to be sepiapterin reductase (SR)-deficient by investigations of pterins in cytokine stimulated fibroblasts. There was no detectable SR activity in the non-stimulated fibroblasts and mutation analysis revealed a homozygous Arg to Gly exchange at codon 150 (RI50G). This is the third case found with SR deficiency characterized by a severe monoamine neurotransmitters deficiency without hyperphenylalaninemia.
INTRODUCTION
Tetrahydrobiopterin (BH 4 ) is a natural cofactor of aromatic amino acid hydroxylases and nitric oxide synthase (1). It is synthesized from GTP by the enzymes GTP cyclohydrolase I (GTPCH), 6-pyruvoyl-tetrahydropterin synthase (PTPS), and sepiapterin reductase (SR) (Figure 1 ). The last two-step reduction of 6-pyruvoyl-tetrahydropterin (PTP) to BH 4 can be alternatively catalyzed by the enzymes aldose reductase (AR) and carbonyl reductase (CR). During hydroxylation of phenylalanine to §First two authors contributed equally tyrosine by phenylalanine-4-hydroxylase, tyrosine to L-Dopa by tyrosine-3-hydroxylase, and tryptophan to 5-hydroxytryptophan by tryptophan-5-hydroxylase, BH 4 is oxidized to carbinolamine-4a-tetrahydrobiopterin which is subsequently reduced back to BH 4 by the enzymes pterin-4a-carbinolamine dehydratase and dihydropteridine reductase (not shown).
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:p::ry~. ·_ru k ., Sepllpterin (S) Figure 1 . De novo biosynthesis of BH 4 from GTP and the proposed salvage pathway. Under normal physiological conditions PTP is reduced to BH 4 via 2'-oxo-TP and I'-oxo-TP by SR. In the absence of SR I' -oxo-TP is oxidized non-enzymatically to sepiapterin which is reduced to BH 4 by CR and dihydrofolate reductase (DHFR) (salvage pathway).
The classical forms of BH 4 deficiencies are characterized by severe monoamine neurotransmitters deficiency accompanied by hyperphenylalaninemia (2). They are caused by autosomal recessive mutations in genes encoding for the enzymes involved in the BH 4 biosynthesis or regeneration; e.g. GTPCH, PTPS, and DHPR (3). Pterin-4a-carbinolamine dehydratase deficiency is a benign form of BH 4 deficiency characterized by transient hyperphenylalaninemia and normal brain neurotransmitters. Autosomal dominant GTPCH deficiency (Dopa-responsive dystonia, DRD) (4) and the recently discovered autosomal recessive SR deficiency (5) present phenotypically without hyperphenylalaninemia. In contrast to classical forms of B~deficiency, SR deficiency and DRD can not be detected by the neonatal screening for phenylketonuria (PKU). Howeyer, these· patients can be detected by measurement of the neurotransmitter
